Chromosomes, Cancer and the Cancer Genome Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What are the features in cancer genome

A
  • aneuploidy
  • copy number changes
  • double minutes
  • chromothripsis
  • translocation
  • telomeres
  • point mutations
  • epigenetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

CIN

A
  • loss, gain or rearrangements of chromosomes
  • prognostic hallmark of solid and haematological cancers
  • cause or effect of carcinogenesis
  • thought to arise through errors in chromosome duplication and or segregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the two types of CIN

A
  • Numerical - gain or loss of whole chromosomes

- structural - gain or loss of individual chromosomal regions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is aneuploidy

A
  • deviation from normal number of chromosomes
  • common in cancer
  • defects in chromosome segregation in cell division
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are copy number alterations

A
  • regions within chromosomes which are lost
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does double minutes mean?

A
  • extrachromosomal circular fragments
  • replicate in the nucleus
  • lack centromere and telomeres
  • not rare - found in 50%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is chromothripsis?

A
  • mechanism which gives rise to double minutes
  • chromosome shattering and random reassembly
  • loss of key regions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe translocations

A
  • one chromosomal region is moved from one region to another chromosome
  • two forms : balanced or imbalanced
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are fusion genes?

A
  • hybrid genes, formed from two separate genes
  • sometimes lead to functional proteins with oncogenic properties
  • eg. BCR-ABL and the philadelphia chromosome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe Gleevec/Imatinib

A
  • introduced in the 1990s
  • 5 year CML survival before gleevec = 30%
  • 5 year survival with gleevec = 89%
  • can only be used in Ph+ cancers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe inversions with an example

A
  • EML4-ALK fusion gene
  • EML4 and ALK inverted
  • can give rise to solid tumour
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What drug targets ALK?

A
  • crizotinib
  • approved after phase 1 trial
  • 82 patients, ALK rearranged lung cancer
    response rate : 57% (expt. 10%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe telomeres

A
  • repetitive sequences at chromosome ends

- protect chromosome against fusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the end replication problem?

A
  • telomeres role to fix
  • during each cell division, small part of chromosome at the ends are lost
  • when telomere becomes too short, (critical point) cell recognises and induced apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is telomerase?

A
  • ribonucleoprotein : protein - reverse transcriptase (TERT), RNA template (TERC)
  • maintain telomeres, enables cell survival
  • active in stem cells, inactive in somatic cells
  • active in 90% of cancers
  • cancer cells escape the apoptotic signal which usually kicks in after certain number of cell divisions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the ALT pathway?

A
  • alternative lengthening of telomeres
  • found in 10% cancers
  • preponderance in certain cancer types eg. bone
  • poor prognosis through CIN
  • mediated by homologous recombination
17
Q

What are point mutations?

A
  • mutations which impact single nucleotides

- insertions and deletions (frame shift), substitutions (silent, missense, nonsense)

18
Q

Are all mutations equal?

A
  • no
  • driver mutations : causally implicated in cancer
    passenger : does not contribute to cancer
19
Q

How are different mutations identified?

A
  • sequence the genome
20
Q

What are the 3 forms of epigenetic mechanisms?

A
  • DNA methylation
  • Histone modification
    non-coding RNAs (ncRNAs)
21
Q

What is DNA methylation?

A
  • addition of a methyl group to DNA
  • CpG dinucleotides
  • repetitive sequences
  • CpG islands in promoters
  • causes transcriptional repression
22
Q

DNA methylation in cancer

A
  • local hypermethylation - TSGs
  • global hypomethylation
  • mutations of DNA methyltransferase genes eg. DNMT3a in AML
23
Q

What are histone modifications?

A
  • acetylated
  • methylated
  • phosphorylated
  • contribute to control of gene expression via chromatin compaction
24
Q

Histone modifications in cancer

A
  • global changes in histone modifications - levels of modifiers
  • modifiers can be mutated in cancer eg. MLL2 in follicular lymphoma
  • HDAC inhibitors as therapy - vorinostat and romidepsin in T cell lymphoma